PF-Atlas › Clinical Trials › NCT04112602
Respiratory Cathepsins, Proteases Inhibitors and Glycosaminoglycans in Mucopolysaccharidosis
Sputum · Not specified
Registry ID
NCT04112602
Phase
Not specified
Status
Completed
Drug / intervention
Sputum
Sponsor
University Hospital, Tours
Start
2019-11-12
About this trial
Sputum is evaluated in NCT04112602, a idiopathic pulmonary fibrosis study sponsored by University Hospital, Tours. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT04112602 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.